A detailed history of Bain Capital Life Sciences Investors, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 1,111,910 shares of CCCC stock, worth $4.39 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
1,111,910
Previous 1,111,910 -0.0%
Holding current value
$4.39 Million
Previous $5.14 Million 23.36%
% of portfolio
1.14%
Previous 1.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.05 - $8.1 $122,715 - $245,430
-30,300 Reduced 2.65%
1,111,910 $5.14 Million
Q1 2024

May 15, 2024

SELL
$5.3 - $11.0 $2.65 Million - $5.5 Million
-500,000 Reduced 30.45%
1,142,210 $9.33 Million
Q4 2021

Feb 14, 2022

BUY
$29.39 - $46.86 $29 - $46
1 Added 0.0%
1,642,210 $52.9 Million
Q4 2020

Feb 16, 2021

BUY
$22.8 - $37.05 $37.4 Million - $60.8 Million
1,642,209 New
1,642,209 $54.4 Million

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $193M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.